Clinical characteristics and outcomes of children with stage 3-5 chronic kidney disease

被引:57
|
作者
Tran Thi Mong Hiep [1 ]
Ismaili, Khalid [2 ]
Collart, Frederic [3 ]
Van Damme-Lombaerts, Rita [4 ]
Godefroid, Nathalie [5 ]
Ghuysen, Marie-Sophie [6 ,7 ]
Van Hoeck, Koen [8 ]
Raes, Ann [9 ]
Janssen, Francoise [2 ]
Robert, Annie [10 ]
机构
[1] Univ Pham Ngoc Thach, Dept Pediat, Nhi Dong Hosp Grall 2, Ho Chi Minh City, Vietnam
[2] Univ Libre Bruxelles, Dept Pediat Nephrol, Hop Univ Enfants Reine Fabiola, Brussels, Belgium
[3] Free Univ Brussels, Hop Univ Brugmann, Dept Nephrol, B-1020 Brussels, Belgium
[4] UZ Gasthuiberg, Dept Pediat Nephrol & Organ Transplantat, Leuven, Belgium
[5] Catholic Univ Louvain, Dept Nephrol, B-1200 Brussels, Belgium
[6] Ctr Hosp Chretien, Dept Pediat Nephrol, Liege, Belgium
[7] Ctr Hosp Univ Liege, Liege, Belgium
[8] Univ Ziekenhuis Antwerpen, Dept Pediat Nephrol, Edegem, Belgium
[9] Univ Ziekenhuis Gent, Dept Pediat Nephrol, Ghent, Belgium
[10] Catholic Univ Louvain, Dept Epidemiol & Biostat, B-1200 Brussels, Belgium
关键词
End stage renal failure; Mortality; Primary renal disease; Renal replacement therapy; CHRONIC-RENAL-FAILURE; GLOMERULAR-FILTRATION-RATE; EPIDEMIOLOGY; GUIDELINES; INFANTS;
D O I
10.1007/s00467-009-1424-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The aim of this study was to report on the clinical characteristics and outcomes of Belgian children with chronic kidney disease (CKD). Between 2001 and 2005, we followed 143 new successive patients younger than 20 years of age with a glomerular filtration rate of < 60 ml/min/1.73 m(2) prospectively in a Belgian department of pediatric nephrology. The incidence of diagnosed CKD was 11.9 per million child population (pmcp), and the incidence of renal replacement therapy was 6.2 pmcp. There were 67% patients in CKD stage 3, 19% in CKD stage 4 and 14% in CKD stage 5. Patients with congenital anomalies of the kidney and urinary tract (CAKUTs), hereditary diseases and glomerular diseases were diagnosed at a median age of 1, 2 and 10 years, respectively. CAKUTs were the main causes of CKD, accounting for 59% of all cases. After 3, 4 and 5 years of follow-up, 27, 31 and 38% of patients treated conservatively, respectively, reached end-stage renal failure (ESRF). The progression rate to ESRF was eightfold higher in patients with CKD stage 4 than in those with CKD stage 3. Among our patient group, hereditary diseases progressed more rapidly to ESRF than CAKUTs. Transplantation was performed preemptively in 22% of these children. Infections and cardiovascular diseases were the main causes of death.
引用
收藏
页码:935 / 940
页数:6
相关论文
共 50 条
  • [21] Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3-5
    Dzgoeva, Fatima U.
    Remizov, Oleg, V
    Botcieva, Victoria Kh
    Goloeva, Victoria G.
    Malakhova, Nina G.
    Ikoeva, Zarina R.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (06) : 731 - 737
  • [22] INTERACTION OF SCLEROSTIN AND OSTEOPROTHERIN IN THE DEVELOPMENT OF VASCULAR CALCIFICATIONS AT STAGE 3-5 OF CHRONIC KIDNEY DISEASE
    Dzgoeva, Fatima
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [23] Predictive value of alfacalcidol on chronic kidney disease progression in patients with ckd stage 3-5
    Briet, M.
    Collin, C.
    Gauci, C.
    Froissart, M.
    Houillier, P.
    Laurent, S.
    Boutouyrie, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 23 - 23
  • [24] DIPYRIDAMOLE IMPROVES PATIENT AND RENAL SURVIVAL IN CHRONIC KIDNEY DISEASE STAGE 3-5 PATIENTS
    Hung, Chi-Chih
    Yang, Mei-Li
    Hwang, Shang-Jyh
    Chen, Hung-Chen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 126 - 126
  • [25] Analysis of blood gas beyond bicarbonate in outpatients with stage 3-5 chronic kidney disease
    Bozaci, Ilter
    Dogan, Ali Nazmi Can
    Aktar, Merve
    Mahser, Alev
    Yildirim, Gizem
    Serel, Ali
    Tatar, Erhan
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2020, 45 (06): : 891 - 898
  • [26] MALNUTRITION, INFLAMMATION, AND ATHEROSCLEROSIS SYNDROME COMPONENTS PREDICTS POOR CARDIOVASCULAR OUTCOMES IN PATIENTS WITH STAGE 3-5 CHRONIC KIDNEY DISEASE
    Solak, Yalcin
    Yilmaz, Mahmut Ilker
    Caglar, Kayser
    Saglam, Mutlu
    Yaman, Halil
    Sonmez, Alper
    Unal, Hilmi Umut
    Gok, Mahmut
    Gaipov, Abduzhappar
    Kayrak, Mehmet
    Eyileten, Tayfun
    Turk, Suleyman
    Vural, Abdulgaffar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 383 - 383
  • [27] HbA1C variability is not associated with renal outcomes in diabetic nephropathy with chronic kidney disease stage 3-5
    Lee, Mei-Yueh
    Chen, Szu-Chia
    Hsu, Wei-Hao
    Lin, Kun-Der
    Hsiao, Pi-Jung
    Shin, Shyi-Jang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S145 - S145
  • [28] The demographic characteristics of children with chronic kidney disease stages 3-5 in South East England over a 5-year period
    Kim, Jon Jin
    Booth, Caroline J.
    Waller, Simon
    Rasmussen, Pernille
    Reid, Christopher J. D.
    Sinha, Manish D.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2013, 98 (03) : 189 - 194
  • [29] The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5
    Karunaratne, Kushan
    Stevens, Paul
    Irving, Jean
    Hobbs, Helen
    Kilbride, Hannah
    Kingston, Richard
    Farmer, Chris
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (08) : 2107 - 2116
  • [30] Effect of Aggressive Osteodystrophy Management on Clinical Outcomes in Stage 5 Chronic Kidney Disease
    Byham-Gray, Laura
    Drasher, Tammy
    Deckman, Karen
    Graham, Diane
    Liftman, Carol
    Roberto, Linda
    Peiffer, Phyllis
    Denmark, Robert
    JOURNAL OF RENAL NUTRITION, 2009, 19 (04) : 321 - 333